NCT02837718

Brief Summary

Background Peripheral nerve blocks with use of USG allowed visualisation of the structures and nerves and made the block administrations safe, quick and comfortable. However there are few publications concerning the minimum local anesthetic volume capable of providing blocks. In this study the investigastors aimed to find Minimum Effective Volume Of Local Anesthetic For Ultrasound-Guided Axillary Brachial Plexus Block in hand, elbow and forehand operations. Materials \& Methods A total of 55 ASA I-II patients underwent hand surgery operation by administering USG guided-axillary brachial plexus blockage were included in the study. Ulnar, median and radial nerves were seen and the minimum effective local anesthetic volume was investigated starting with total 21 ml of %0.5 bupivacain. After accomplishing the blockage, volume was decreased by 0.5 for each nerves. Block administration time, block onset times, anesthesia times and time to first analgesic requirement were recorded.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
55

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Dec 2014

Shorter than P25 for phase_4

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2014

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2015

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 17, 2016

Completed
6 months until next milestone

First Posted

Study publicly available on registry

July 20, 2016

Completed
Last Updated

January 13, 2020

Status Verified

December 1, 2018

Enrollment Period

4 months

First QC Date

January 17, 2016

Last Update Submit

January 8, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Minimum effective volume of bupivacain %0.5

    Ulnar, median and radial nerves were seen and the minimum effective local anesthetic volume was investigated starting with total 21 ml of %0.5 bupivacain. After accomplishing the blockage, volume was decreased by 0.5 for each nerves

    1 hour

Secondary Outcomes (1)

  • first analgesic requirement

    1 day (0,1, 2, 4, 6, 8, 10, 12, 18, 24 hours)

Study Arms (1)

Bupivacaine 0,5% Single arm study

OTHER

Bupivacaine 0,5% Single arm study

Procedure: bupivakain % 0,5

Interventions

Bupivacaine 0,5% The study method was a step-up/step-down sequence model where the dose for following patients was determined by the outcome of the preceding block. The starting dose of bupivacaine was 5 mL per nerve. In the case of block failure, the dose was increased by 0.5 mL per nerve. Conversely, block success resulted in a reduction in dose by 0.5 mL per nerve. Each of the three nerves was treated as a separate entity. Dose adjustments were made to each nerve individually. The volume dose was increased in 0.5 mL at every 5 consecutive cases regardless of the result of the previous block in order to minimize bias occurence. A blinded assistant assessed sensory and motor blockade at 5-min intervals up to 30 min.

Bupivacaine 0,5% Single arm study

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • were age over 18 and under 65 years
  • informed consent (IC) signed by the patient
  • indication for brachial plexus block (anesthesia and analgesia) in candidates forelective hand surgery
  • ASA physical status I or II according to the American Society of Anesthesiologists
  • body mass index (BMI) \<35 kg/m2.

You may not qualify if:

  • Cognitive impairment or active psychiatriccondition
  • İnfection at the blockade puncture site
  • Bleeding disorders
  • History of local anesthetic allergy
  • Pregnancy
  • The patients does not want this method .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
interventional
Phase
phase 4
Masking
NONE
Purpose
PREVENTION
Intervention Model
SEQUENTIAL
Model Details: A total of 55 ASA I-II patients underwent hand surgery operation by administering USG guided-axillary brachial plexus blockage were included in the study. Ulnar, median and radial nerves were seen and the minimum effective LA volume was investigated starting with total 21 ml of %0.5 bupivacain. After accomplishing the blockage, volume was decreased by 0.5 for each nerves. Block administration time, block onset times, anesthesia times and time to first analgesic requirement were recorded.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

January 17, 2016

First Posted

July 20, 2016

Study Start

December 1, 2014

Primary Completion

April 1, 2015

Study Completion

August 1, 2015

Last Updated

January 13, 2020

Record last verified: 2018-12